FDA to discuss rare side effects type of blood clot from J&J vaccine

The United States recommends a "discontinuation" of single-dose in the administration of the Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. Clots occur in the veins that drain blood from the brain and occur with low platelets. The six cases were women between the ages of 18 and 48.

-~-~~-~~~-~~-~-
Please watch: "Reina Rose interview Phil Cooke Hollywood Christian Producer"
https://www.youtube.com/watch?v=ogBS-do5g9k
-~-~~-~~~-~~-~-